FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

HESTER BIOSCIENCES LTD.

NSE : HESTERBIOBSE : 524669ISIN CODE : INE782E01017Industry : Pharmaceuticals & DrugsHouse : Private

BSE1427.9055.05 (+4.01 %)

PREV CLOSE (Rs.) 1372.85

OPEN PRICE (Rs.) 1348.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 341

TODAY'S LOW / HIGH (Rs.)1336.90 1432.05

52 WK LOW / HIGH (Rs.)1250.95 2347.7

NSE1419.4053.8 (+3.94 %)

PREV CLOSE( Rs. ) 1365.60

OPEN PRICE (Rs.) 1370.00

BID PRICE (QTY) 1419.40 (4)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2761

TODAY'S LOW / HIGH(Rs.) 1332.40 1427.90

52 WK LOW / HIGH (Rs.)1239.3 2350

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

4.77

Dividend Yield(%)

0.49

TTM EPS (Rs.)

41.56

P/E Ratio

34.36

Book Value (Rs.)

421.62

Face Value (Rs.)

MCap (Rs. in Mn)

12146.95

Price/Earning (TTM)

27.63

Price/Sales (TTM)

4.42

Price/Book (MRQ)

3.39

PAT Margin (%)

11.11

ROCE (%)

10.59

Incorporation Year : 1987

Management Info :

Bhupendra Gandhi - Chairman Rajiv Gandhi - Managing Director

Registered Office :

Address : Meda Adraj , Kadi, , ,
Mehsana,
Gujarat-384441

Phone : 079 – 26445106

Email : mail@hester.in

Website : www.hester.in

Registrars Details :

MUFG Intime India Pvt Ltd.

506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad

Listing : BSE, NSE

NEWS

11Mar Hester Biosciences gets nod to divest
Hester Biosciences has received approval for the divestment of 43.81% eq..

11Mar Hester Biosciences informs about outco
Hester Biosciences has informed that the Board of Directors at the meeti..

05Feb Hester Biosciences informs about board
Hester Biosciences has informed that it submitted a newspaper clipping o..

Financials

	QTR Dec 25	ANNUAL 25
Net Profit	106.69	318.42
Gross Profit	146.42	417.6
Operating Profit	177.51	557.08
Net Sales	703.54	2864.66

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)

2146.70 (3.09%)

M.Cap (Rs. in Cr)1326.24

Haleos Labs (BSE)

1299.00 (3.61%)

M.Cap (Rs. in Cr)392.72

RPG Life Sciences (BSE)

1922.95 (2.35%)

M.Cap (Rs. in Cr)3180.37

Albert David (BSE)

653.15 (6.34%)

M.Cap (Rs. in Cr)372.76

Shareholding Pattern

	PROMOTERS	53.73%
	NON-INSTITUTION	45.76%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

Bandhan BSE Healthc...

0.05

Motilal Oswal BSE H...

0.05

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22